# Conviction (AI-native venture investor)

> Conviction is an AI-native venture investor founded by Sarah Guo. It led Xlue's $35M Seed disclosed November 18, 2026; its actual investment allocation and ownership are undisclosed.

## Profile

- **Reported initial check:** $1M–$25M
- **Check-size evidence basis:** reported
- **Founded:** N/A
- **Headquarters:** United States
- **AUM:** N/A
- **Rounds they lead:** Seed, Series A
- **Rounds they invest:** Seed, Series A
- **Check-size source:** https://www.conviction.com/
- **Last verified:** 2026-11-21

## Links

- [Website](https://www.conviction.com/)

## In-depth investment analysis

Conviction, founded by Sarah Guo, focuses on AI-native businesses and publicly describes a general $1M–$25M check-size mandate, often at seed and Series A. Public portfolio examples include Harvey, Cognition, Mistral, Baseten and Sierra. The published team includes Mike Vernal and Pranav Reddy. On November 18, 2026 Forbes reported Conviction led Xlue's $35M Seed; Reddy described the model thesis as predicting changes in health rather than next symptoms. Conviction's individual amount, stake, fund vintage and Xlue valuation are not disclosed. The firm's range is not evidence of its investment into Xlue.

## Research sources

- [Conviction manager website](https://www.conviction.com/)
- [Forbes founder/lead investor interview](https://tollbit.forbes.com/sites/innovationrx/2026/11/18/a-carnegie-mellon-researcher-raises-35-million-for-clinical-intelligence)

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/fund/conviction-partners
